Working… Menu

Molecular and Cellular Analysis of Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02243397
Recruitment Status : Suspended (Safety)
First Posted : September 17, 2014
Last Update Posted : December 17, 2020
Information provided by (Responsible Party):
Stanford University

Brief Summary:
The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.

Condition or disease
Breast - Female Breast - Male

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular and Cellular Analysis of Breast Cancer
Study Start Date : September 2014
Estimated Primary Completion Date : September 2024
Estimated Study Completion Date : September 2024

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. levels of GM-CSF in plasma [ Time Frame: 10 years ]
    We will be measuring levels of GM-CSF (Granulocyte-macrophayge colony stimulating factor) from the plasma of the patient before during and after the irradiation treatment to study if there is any increase in the GM-CSF production

Biospecimen Retention:   Samples With DNA
blood, cerebrospinal fluid, abdominal fluid, chest fluid

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
breast cancer patients at Stanford Cancer Center

Inclusion Criteria:

  1. Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary consistent with the presentation of a primary breast malignancy.
  2. 18 years of age or older.
  3. Ability to understand and the willingness to sign a written informed consent do

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02243397

Layout table for location information
United States, California
Stanford University Cancer Institute
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Layout table for investigator information
Principal Investigator: Kathleen Horst Stanford University
Layout table for additonal information
Responsible Party: Stanford University Identifier: NCT02243397    
Other Study ID Numbers: BRS0040
First Posted: September 17, 2014    Key Record Dates
Last Update Posted: December 17, 2020
Last Verified: October 2020